1-4 of 4
Ismael Samudio, Ph.D.
Close
Sort by
Journal Articles

Inhibition of Bcl-2 Signaling by Small Molecule BH3 Inhhibitor GX15-070 as a Novel Therapeutic Strategy in AML.

Julie C. Watt, Marina Konopleva, M.D., Ph.D., Rooha Contractor, Ismael Samudio, Ph.D., David Harris, Zeev Estrov, M.D., Jean Viallet, M.D., Michael Andreeff, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2584.
https://doi.org/10.1182/blood.V108.11.2584.2584
Published: 2006
Journal Articles

Relationship between mTOR-Mediated Upregulation of Glycolysis and Chemosensitivity of ALL Blasts.

Olga Frolova, MD, PhD, Daniela Buglio, Ph.D., Ismael Samudio, Ph.D., Teresa McQueen, Hagop Kantarjian, M.D., Mary A. Weiser, M.D., Ph.D., Michael Andreeff, M.D., Ph.D., Marina Konopleva, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1833.
https://doi.org/10.1182/blood.V108.11.1833.1833
Published: 2006
Journal Articles

Rapamycin Analogs Reduce mTORC2 Signaling and Inhibit AKT Activation in AML.

Zhihong Zeng, PhD, Dos D. Sarbassov, Francis J. Giles, M.D., Ismael Samudio, Ph.D., Karen W.L. Yee, C. Ellen Jackson, R.N., B.S.N., David M. Sabatini, M.D., Ph.D., Michael Andreeff, M.D., Ph.D., Marina Konopleva, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 156.
https://doi.org/10.1182/blood.V108.11.156.156
Published: 2006
Journal Articles

ARTS, a Pro-Apoptotic Mitochondrial Septin-Like Protein That Binds to XIAP, Is Silenced in Acute Lymphoblastic and Primitive Acute Myeloblastic Leukemia Cells.

Masato Shikami, M.D., Ph.D., Marina Konopleva, M.D., Ph.D., Ismael Samudio, Ph.D., Koyu Hoshino, M.D., Ph.D., Guillermo Garcia-Manero, M.D., Kensuke Kojima, M.D., Ph.D., Twee Tsao, Teresa McQueen, Michael Andreeff, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3378.
https://doi.org/10.1182/blood.V104.11.3378.3378
Published: 2004